CHO Pharma, Inc. (6586.TWO)
TWD 42.9
(-17.82%)
TWD 42.9
(-17.82%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -277.73 Million TWD | 6.88% |
| 2022 | -302.27 Million TWD | -79.38% |
| 2021 | -170.15 Million TWD | 34.75% |
| 2020 | -258.92 Million TWD | 25.04% |
| 2019 | -323.91 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -56.23 Million TWD | -6.8% |
| 2024 Q1 | -52.65 Million TWD | -0.55% |
| 2023 Q3 | -52.36 Million TWD | 28.05% |
| 2023 FY | - TWD | 6.88% |
| 2023 Q2 | -72.78 Million TWD | 0.0% |
| 2023 Q1 | -72.78 Million TWD | 15.17% |
| 2023 Q4 | -52.36 Million TWD | 0.0% |
| 2022 FY | - TWD | -79.38% |
| 2022 Q4 | -85.79 Million TWD | 0.0% |
| 2022 Q3 | -85.79 Million TWD | 0.0% |
| 2021 FY | - TWD | 34.75% |
| 2020 FY | - TWD | 25.04% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -500.577% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 170.561% |
| Level Biotechnology Inc. | 98.7 Million TWD | 381.378% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -520.781% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -285.122% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -1000.666% |
| GlycoNex Incorporation | -126.82 Million TWD | -118.984% |
| VBI | -6.97 Million TWD | -3883.52% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -93.278% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 1373.411% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -1466.8% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -168.041% |
| Visgeneer Inc. | 973 Thousand TWD | 28643.782% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 18.19% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 129.657% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 378.184% |
| Neith Corporation | -33.61 Million TWD | -726.334% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 71.977% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -15889.119% |
| Enimmune corporation | -228.96 Million TWD | -21.3% |
| TaiRx, Inc. | -208.64 Million TWD | -33.111% |
| EirGenix Inc. | -664.4 Million TWD | 58.199% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 475.8% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 501.676% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 74.078% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -145.549% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 897.207% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -345.503% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -956.011% |
| RBC Bioscience Corporation | 36.54 Million TWD | 859.928% |
| BiOptic Inc. | 65.03 Million TWD | 527.029% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 59.304% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -741.456% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -405.747% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 164.059% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -246.852% |
| NaviFUS Corp. | -55.79 Million TWD | -397.77% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -1573.28% |
| Sinew Pharma Inc. | -163.63 Million TWD | -69.73% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -351.595% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 244.349% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | -22.522% |
| AP Biosciences Inc | -325.51 Million TWD | 14.679% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 73.413% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -674.789% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 1053.419% |
| Intech Biopharm Corporation | -219.58 Million TWD | -26.48% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 58.808% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -517.853% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -72.657% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 142.368% |
| TCI GENE Inc. | 25.98 Million TWD | 1168.977% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -151.027% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 2.133% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -90.266% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 2105.278% |
| PharmaEngine, Inc. | 347.3 Million TWD | 179.967% |
| Savior Lifetec Corporation | 219.6 Million TWD | 226.468% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 261.256% |
| OBI Pharma, Inc. | -855.08 Million TWD | 67.52% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -200.045% |
| Acepodia, Inc. | -764.51 Million TWD | 63.672% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 39.636% |